y 27632 has been researched along with benzyloxycarbonylleucyl-leucyl-leucine aldehyde in 4 studies
| Studies (y 27632) | Trials (y 27632) | Recent Studies (post-2010) (y 27632) | Studies (benzyloxycarbonylleucyl-leucyl-leucine aldehyde) | Trials (benzyloxycarbonylleucyl-leucyl-leucine aldehyde) | Recent Studies (post-2010) (benzyloxycarbonylleucyl-leucyl-leucine aldehyde) |
|---|---|---|---|---|---|
| 1,924 | 3 | 891 | 2,473 | 3 | 1,057 |
| Protein | Taxonomy | y 27632 (IC50) | benzyloxycarbonylleucyl-leucyl-leucine aldehyde (IC50) |
|---|---|---|---|
| Proteasome subunit beta type-11 | Homo sapiens (human) | 1.9893 | |
| Calpain-9 | Homo sapiens (human) | 9.88 | |
| Proteasome subunit alpha type-7 | Homo sapiens (human) | 1.9893 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 3.9 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 3.8999 | |
| Aromatase | Homo sapiens (human) | 0.044 | |
| Indoleamine 2,3-dioxygenase 1 | Homo sapiens (human) | 0.5 | |
| Proteasome subunit beta type-1 | Homo sapiens (human) | 1.0853 | |
| Proteasome subunit alpha type-1 | Homo sapiens (human) | 1.9893 | |
| Proteasome subunit alpha type-2 | Homo sapiens (human) | 1.9893 | |
| Proteasome subunit alpha type-3 | Homo sapiens (human) | 1.9893 | |
| Proteasome subunit alpha type-4 | Homo sapiens (human) | 1.9893 | |
| Proteasome subunit beta type-8 | Homo sapiens (human) | 1.9893 | |
| Proteasome subunit beta type-9 | Homo sapiens (human) | 1.9893 | |
| Proteasome subunit alpha type-5 | Homo sapiens (human) | 1.9893 | |
| Proteasome subunit beta type-4 | Homo sapiens (human) | 1.9893 | |
| Proteasome subunit beta type-6 | Homo sapiens (human) | 1.9893 | |
| Proteasome subunit beta type-5 | Homo sapiens (human) | 0.6088 | |
| Proteasome subunit beta type-10 | Homo sapiens (human) | 1.9893 | |
| Proteasome subunit beta type-3 | Homo sapiens (human) | 1.9893 | |
| Proteasome subunit beta type-2 | Homo sapiens (human) | 2.0443 | |
| Proteasome subunit alpha type-6 | Homo sapiens (human) | 1.9893 | |
| Proteasome subunit alpha-type 8 | Homo sapiens (human) | 1.9893 | |
| Proteasome subunit beta type-7 | Homo sapiens (human) | 1.9893 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
| Hashimoto, K; Kawagoe, J; Kurachi, H; Morishige, K; Ohta, T; Takahashi, K; Takahashi, T; Takata, K; Tsutsumi, S; Yin, L | 1 |
| Byers, B; Byrne, J; Cord, B; Dolmetsch, RE; Gujar, P; Kee, K; Langston, W; Nguyen, HN; Palmer, TD; Pera, RR; Schüle, B; Shcheglovitov, A | 1 |
| Bi, E; Hawke, DH; Huang, S; Jiang, Y; Li, X; Liu, DX; Lu, Z; Majumder, S; Wang, T; Wang, Y; Zheng, Y; Zhou, Q | 1 |
4 other study(ies) available for y 27632 and benzyloxycarbonylleucyl-leucyl-leucine aldehyde
| Article | Year |
|---|---|
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
Fasudil-induced hypoxia-inducible factor-1alpha degradation disrupts a hypoxia-driven vascular endothelial growth factor autocrine mechanism in endothelial cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amides; Autocrine Communication; Cell Hypoxia; Cell Movement; Cell Nucleus; Drug Screening Assays, Antitumor; Endothelial Cells; Enzyme Activation; Gene Expression Regulation; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Leupeptins; Myosin Light Chains; Neovascularization, Pathologic; Phosphorylation; Protein Processing, Post-Translational; Protein Transport; Pyridines; rho-Associated Kinases; Ubiquitination; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2008 |
LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress.
Topics: Amides; Amino Acid Substitution; Animals; Cell Death; Cell Differentiation; Dopamine; Female; Humans; Hydrogen Peroxide; Induced Pluripotent Stem Cells; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Leupeptins; Mesencephalon; Mice; Middle Aged; Mutation; Neurons; Oxidative Stress; Oxidopamine; Parkinson Disease; Phenotype; Protein Serine-Threonine Kinases; Pyridines; rho-Associated Kinases | 2011 |
PKM2 phosphorylates MLC2 and regulates cytokinesis of tumour cells.
Topics: Amides; Animals; Aurora Kinase B; Brain Neoplasms; Cardiac Myosins; Carrier Proteins; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Cytokinesis; ErbB Receptors; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; Leupeptins; Membrane Proteins; Mice; Mice, Nude; Mitosis; Myosin Light Chains; Phosphorylation; Proto-Oncogene Proteins; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins p21(ras); Pyridines; Pyruvate Kinase; ras Proteins; rho-Associated Kinases; RNA Interference; RNA, Small Interfering; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2014 |